Sanofi 20F 2006 Annual report | SNY Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: Abrika, accurate, accurately, acne, adenocarcinoma, ADH, ADHD, adipose, adrenoreceptor, Agreal, Alaska, Albany, alendronate, Alfort, allegra®, Alstom, aluminum, ambien®, amibegron, amyloid, angiokinase, antigen, antihypertensive, antiresorptive, apportioned, arisen, artesunate, ascertain, ASH, ATHENA, Atlanta, attestation, AUD, authentic, Autopen, Avastin, Baltimore, Beijing, bench, benzoyl, bioequipotency, BioMedica, biotinylated, bivalent, blockade, bradykinin, Brindisi, brunt, budgetary, bureau, canary, cannabinoid, capecitabine, car, carboplatin, CASSIOPEA, causation, CDHP, celivarone, cerebrovascular, cervical, Cham, chemoradiotherapy, chiefly, cilostazol, CLARINET, claudication, clearer, Clin, clindamycin, CLL, closest, Cluzel, cognitive, cohort, cold, commercialisation, commercialise, commingling, Committeeat, comorbidity, compensatory, Concession, Concurrently, confidence, congenital, congressional, Consortium, contemporary, cope, COSO, counterfeit, counterfeiting, courtLandgericht, Cox, CPA, Cytosine, CZK, dealt, Debroux, deceleration, Decommissioning, decree, deficit, Density, depakine®, deployment, deregulate, deteriorate, devastating, DH, Dianicline, differentiated, dihydropyrimidine, DILIPO, dinner, Dodge, Donna, doughnut, DPD, DREAM, DVT, dysglycemic, dysplasia, easier, economy, eIPV, eloxatine®, empowerment, Endocrinologic, England, enregistrement, Environnement, EQUINOX, eroded, escalating, fallen, favour, Fawdon, feed, felt, fighting, flagship, fluoropyrimidine, FLUPAN, flutter, Fontaine, freehold, GAD, Gardasil, Garijo, gastroesophageal, gemcitabine, genital, Gent, Georg, Georgetown, glycosylated, GRACE, grain, Gregory, Guanine, Guy, hard, Hawaii, hemoglobin, Herbicide, hierarchy, hit, holderprior, hole, Holtzbrinck, HPV, hybrid, hydroxide, hypercholesterolemia, hyperinflationary, Icatabant, Icatibant, IFG, IGT, IKK, Ilepatril, inadmissible, INALCO, indistinguishable, Ingenuity, inIncome, inlight, Int, Intercell, interfering, intermittent, intuitively, IPT, Irace, Iraq, Irvine, Iscover, ISTH, Journal, Karen, Korean, Labie, larotaxel, Laurence, Leiden, Liberty, Libragen, Linehan, lispro, load, loading, London, losartan, lovenox®, lyophilized, MAIA, mania, manic, Marcy, MASCOT, McClung, MDD, meant, Medac, Medecine, menopause, microbial, Midy, mild, mistakenly, Montpellier, mood, moratorium, mounting, Multaq, multikinase, multivalent, Mumford, MWLH, myeloid, NAQ, Nephrol, Nestl, neuropathic, nineteenth, node, normoglycemia, Novexel, nullification, nullity, Nycomed, ocular, offensive, onlyafter, onNet, onthe, osteoporotic, Owen, Oxford, oxonate, Panama, paradigm, parenteral, Path, pave, payload, PCAOB, PDVI, PE, pendency, Pentaxim, peroxide, petitioner, PF, pharmacodynamic, pharmacokinetic, pharmacologist, Pharmacopoeia, phenotypic, phospodiester, plavix®, POC, Porcellati, posed, powder, preapproval, predated, prodrug, prototype, PSTC, Psychiatric, psychiatry, PTE, pyrimidine, Quetigny, rachat, reassuring, recourse, Redwood, regression, reimportation, remittance, repatriation, reportedly, resubmitted, resurfacing, rheumatoid, rice, Rotateq, Rubella, saredudant, sat, Satavaptan, Scoppito, sedentary, sequelae, SERENADE, Seventeen, shelf, SHINE, shRNA, sigma, Silverman, siRNA, sJNDA, skeletal, slipped, slotted, slowdown, SMC, SmPC, Soc, solostar, sorbate, soughtprior, sparing, SPC, Speaker, stagnated, steroid, streamline, style, sublicensed, Sumitomo, surface, Surinabant, surrogate, Synthon, Taiho, TaipeiEcole, tegafur, telithromycin, tentative, text, Thai, theEcole, theInstitut, thesecondary, thousand, tocolytic, toddler, Toulouse, TPF, Transfert, Treadway, Treasurer, trioxaquine, TRIST, TroVax, Tucson, tumour, UCB, Ujpest, ultra, underwent, unexpired, unhealthy, unissued, unprecedented, unqualified, unsafe, unsatisfied, unutilized, uplifted, uptake, USDA, Vactech, vasopeptidase, Veolia, veralipride, Veresegyhaz, Verlagsgruppe, VICP, Vit, Vitter, VKA, von, vulnerability, Washington, Waterhouse, Wayne, weighed, whistleblower, withPlasmodium, worsening, wrongly, Xyzal, YTD

Removed: abstinence, Akzo, amortize, antidiuretic, Appx, aquaretic, Bagneux, breadth, Caisse, canceled, cardiac, certificat, circumvention, complication, conditional, constructed, content, correct, cotation, coupled, deadline, debited, dedicate, delivered, destruction, diastolic, discontinuance, divert, documented, doubled, enabled, endocannabinoid, enrollment, environmentally, EPA, extremely, financier, fluoxetine, forecasted, Fujisawa, fumagillin, Gentilly, habilit, insured, integrate, integrating, lapsed, leasing, literature, loan, Lorex, mentioning, mixed, MOSAIC, Nicole, osanetant, overriding, Peru, pre, precisely, Presse, Puerto, pure, realization, reconciled, refinance, relapse, renew, rent, Rep, revolving, sharing, shock, short, simplified, Sorbonne, sound, SR, Sydney, thromboembolic, unconditional, underway, underwritten, Valorisation, vertical, vital, wholesaler, yearly


By:		/s/ Gérard Le Fur
		Gérard Le Fur
		Chief Executive Officer

Sanofi (SNY) 20-F2006 FY Annual report (foreign)

Content analysis